Circulating Biomarkers Predict Immunotherapeutic Response in Hepatocellular Carcinoma Using a Machine Learning Method DOI Creative Commons
Zhijun Dai, Chao Chen, Ziyan Zhou

et al.

Journal of Hepatocellular Carcinoma, Journal Year: 2024, Volume and Issue: Volume 11, P. 2133 - 2144

Published: Oct. 1, 2024

Immune checkpoint inhibitor (ICI) therapy is a promising treatment for cancer. However, the response rate to ICI in hepatocellular carcinoma (HCC) patients low (approximately 30%). Thus, an approach predict whether patient will benefit from required. This study aimed design classifier based on circulating indicators identify suitable therapy.

Language: Английский

The comprehensive analysis of gut microbiome and spleen transcriptome revealed the immunomodulatory mechanism of Dendrobium officinale leaf polysaccharide on immunosuppressed mice DOI
Jingrui Li, Wenyang Tao, Wanyi Zhou

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 278, P. 134975 - 134975

Published: Aug. 22, 2024

Language: Английский

Citations

2
Circulating Biomarkers Predict Immunotherapeutic Response in Hepatocellular Carcinoma Using a Machine Learning Method DOI Creative Commons
Zhijun Dai, Chao Chen, Ziyan Zhou

et al.

Journal of Hepatocellular Carcinoma, Journal Year: 2024, Volume and Issue: Volume 11, P. 2133 - 2144

Published: Oct. 1, 2024

Immune checkpoint inhibitor (ICI) therapy is a promising treatment for cancer. However, the response rate to ICI in hepatocellular carcinoma (HCC) patients low (approximately 30%). Thus, an approach predict whether patient will benefit from required. This study aimed design classifier based on circulating indicators identify suitable therapy.

Language: Английский

Citations

2